Condition | RAD/HGMP | (%) | RAD/controls | (%) | OR | 95% CI | P a |
---|---|---|---|---|---|---|---|
RAD/no RAD | 8/5 | (61) | 368/43445b | (0.83) | 188.89 | 55.9ā665.91 | <0.001 |
Ankylosing spondylitis | 4/9 | (30.7) | 5/43832b | (0.01) | 2697.4 | 531.6ā13586.8 | <0.001 |
Systemic lupus erythematosus | 2/11 | (15.3) | 15/43822b | (0.03) | 449.5 | 0ā2391.1 | <0.001 |
Polymyositis/dermatomyositis | 1/12 | (7.6) | 18/43837b | (0.04) | 187.2 | - | 0.006 |
Juvenile rheumatoid arthritis | 1/12 | (7.6) | 14/43823b | (0.03) | - | - | 0.004 |
Rheumatoid arthritis | 0/13 | (0) | 272/43565b | (0.62) | 0.0 | 0ā63.7 | 0.9 |
Other RAD* | 0/13 | (0) | 44/43793b | (0.1) | 0.0 | 0ā407.1 | 0.9 |
B27 (+)/(-) | 4/9 | (30.7) | 27/638c | (4) | 7.27 | 1.86ā26.2 | 0.005 |